Newsroom
Sorted by: Latest
-
Neighborhood Intelligence, Inc. Announces $25 Million Share Repurchase Program
NASHVILLE, Tenn.--(BUSINESS WIRE)--Neighborhood Intelligence, Inc. (Nasdaq: NXH) (the “Company”), today announced that its Board of Directors has authorized a share repurchase program under which the Company may repurchase up to $25 million of its outstanding common stock (the “Repurchase Program”). Under the Repurchase Program, the Company may repurchase shares from time to time through open market purchases, privately negotiated transactions or other methods, including through arrangements wi...
-
Omeros Corporation Reports Third Quarter 2026 Financial Results
SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) today announced recent highlights and developments as well as financial results for the third quarter ended September 30, 2026, which include: Third Quarter and Recent Highlights YARTEMLEA® (narsoplimab-wuug), the first and only approved treatment for stem cell transplant-associated thrombotic microangiopathy (“TA-TMA”), an often-lethal complication of stem cell transplantation, generated gross revenue of $41.8 million in the third qua...
-
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year-Ended September 30, 2026
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today reported financial results for its fiscal fourth quarter and year-ended September 30, 2026. “During fiscal 2026 we made significant progress across our virology and immunology portfolios. In RSV, we completed enrollment in LOTUS, a Phase 2b trial of zelicapavir in pediatric patients...
-
Arrow Electronics to Present at Upcoming Investor Conference
CENTENNIAL, Colo.--(BUSINESS WIRE)--Arrow Electronics, Inc. (NYSE:ARW) today announced its management is scheduled to present at the following investor event to discuss Arrow’s business and strategy:On Nov. 30 at 2:55 p.m. ET, William Austen, interim chief executive officer, will participate in a fireside chat at the 2026 UBS Global Technology and AI Conference.Live webcasts and replays can be accessed via the events page on Arrow’s Investor Relations website, investor.arrow.com.About Arrow Elec...
-
Lattice Extends Space Heritage with On-Orbit Milestone in TESAT Optical Communication Terminals
HILLSBORO, Ore. & BACKNANG, Germany--(BUSINESS WIRE)--Lattice Semiconductor (NASDAQ: LSCC), the low power programmable and platform firmware leader, today announced that its low power, radiation-resilient Lattice Nexus™ FPGAs have surpassed one year of on-orbit operation in TESAT optical communication terminals. Since launch, the FPGAs have delivered consistent performance in the demanding application of space-based laser communication at 10 Gbps, adding to Lattice’s space heritage of thousands...
-
Moody’s Names Timothy Bhatt as Chief Information Officer
NEW YORK--(BUSINESS WIRE)--Moody’s Corporation (NYSE: MCO) announced today that it has named Tim Bhatt to the newly created role of Chief Information Officer (CIO), effective December 7th, and that he will join the company’s Executive Leadership Team. Mr. Bhatt, who has served as Chief Technology Officer (CTO) of Moody’s Ratings since 2018, will also continue in that role. As CIO, Mr. Bhatt will lead Moody’s enterprise technology strategy, AI enablement, and information security, with responsib...
-
Type One Energy Announces Leadership Transition
KNOXVILLE, Tenn.--(BUSINESS WIRE)--Type One Energy’s Board of Directors today announced the appointment of Charlie Baynes-Reid as Chief Executive Officer. Baynes-Reid, who joined the company in 2023 and currently serves as Chief Financial Officer, succeeds Christofer Mowry, who has stepped down for personal reasons. During his tenure, Mowry played a pivotal role in establishing Type One Energy’s differentiated original equipment manufacturer (OEM) business model and advancing its capital-light,...
-
NYSE to Commence Delisting Proceedings Against Accendra Health, Inc. (ACH)
NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock — ticker symbol ACH —of Accendra Health, Inc. (the “Company”) from the NYSE. Trading in the Company’s common stock will be suspended immediately. NYSE Regulation has determined that the Company’s common stock is no longer suitable for listing based on “abnormally low selling price” levels, pursuant to...
-
KBRA Assigns Preliminary Ratings to Morgan Stanley Residential Mortgage Loan Trust 2026-INV3 (MSRM 2026-INV3)
NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to 38 classes of mortgage pass-through certificates from Morgan Stanley Residential Mortgage Loan Trust 2026-INV3 (MSRM 2026-INV3). The transaction consists of 875 fixed-rate mortgages (FRMs) with an aggregate principal balance of $342.1 million as of the November 1, 2026 cut-off date. The underlying pool consists of loans that are collateralized by investment properties (80.5%) and second homes (19.5%). KBRA’s rating approach incorpor...
-
Perfect Moment Announces Executive Leadership and Board Transitions to Support Next Phase of Growth
LONDON--(BUSINESS WIRE)--Perfect Moment Ltd. (OTCQB: PMNT) (“Perfect Moment” or the “Company”), the high-performance, luxury lifestyle brand that fuses technical excellence with fashion-led designs, today announced a series of executive leadership and Board of Directors transitions designed to support the Company’s next phase of growth, strengthen its leadership capabilities and further align executive responsibilities with the Company’s strategic priorities.Effective November 15, 2026, Suzy Bis...